DDrare: Database of Drug Development for Rare Diseases

Urine sample (DrugBank: -)

3 diseases

ID	Disease name (Link within this page)	Number of trials
49	Systemic lupus erythematosus	1
51	Scleroderma	1
61	Autoimmune hemolytic anemia	1

49. Systemic lupus erythematosus [ 827 clinical trials, 638 drugs, (DrugBank: 168 drugs), 108 drug target genes, 191 drug target pathways]

Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 827 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03575156 (ClinicalTrials.gov)	September 20, 2018	7/6/2018	Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis	Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis	Systemic Lupus Erythematosus;Systemic Scleroderma	Biological: blood sample;Biological: urine sample	University Hospital, Bordeaux	NULL	Active, not recruiting	18 Years	N/A	All	208	N/A	France

51. Scleroderma [ 466 clinical trials, 536 drugs, (DrugBank: 142 drugs), 110 drug target genes, 210 drug target pathways]

Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 466 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03575156 (ClinicalTrials.gov)	September 20, 2018	7/6/2018	Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis	Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis	Systemic Lupus Erythematosus;Systemic Scleroderma	Biological: blood sample;Biological: urine sample	University Hospital, Bordeaux	NULL	Active, not recruiting	18 Years	N/A	All	208	N/A	France

61. Autoimmune hemolytic anemia [ 90 clinical trials, 72 drugs, (DrugBank: 23 drugs), 19 drug target genes, 147 drug target pathways]

Searched query = "Autoimmune hemolytic anemia", "AIHA", "WAIHA", "Cold agglutinin disease", "CAD", "Paroxysmal cold hemoglobinuria", "MAIHA", "Evans syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 90 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04005638 (ClinicalTrials.gov)	February 2, 2019	17/6/2019	Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia	Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia	Immune Thrombocytopenia;Autoimmune Hemolytic Anemia;Autoimmune Neutropenia	Biological: blood sample;Biological: urine sample	University Hospital, Bordeaux	Ministry for Health and Solidarity, France	Recruiting	18 Years	N/A	All	200		France